Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15389235rdf:typepubmed:Citationlld:pubmed
pubmed-article:15389235lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C1524081lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C1516050lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C1552601lld:lifeskim
pubmed-article:15389235lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:15389235pubmed:issue3lld:pubmed
pubmed-article:15389235pubmed:dateCreated2004-9-24lld:pubmed
pubmed-article:15389235pubmed:abstractTextWe hypothesized that the benefit from ramipril on cardiac events and on left ventricular end-systolic volume (ESVI) in the Angiotensin-converting enzyme inhibition Post-revascularization Study (APRES) randomized controlled trial (RCT) was associated with long-term improvement.lld:pubmed
pubmed-article:15389235pubmed:languageenglld:pubmed
pubmed-article:15389235pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15389235pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15389235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15389235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15389235pubmed:statusMEDLINElld:pubmed
pubmed-article:15389235pubmed:monthSeplld:pubmed
pubmed-article:15389235pubmed:issn1097-6744lld:pubmed
pubmed-article:15389235pubmed:authorpubmed-author:GrandePeerPlld:pubmed
pubmed-article:15389235pubmed:authorpubmed-author:SteffensenRol...lld:pubmed
pubmed-article:15389235pubmed:authorpubmed-author:Kjøller-Hanse...lld:pubmed
pubmed-article:15389235pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15389235pubmed:volume148lld:pubmed
pubmed-article:15389235pubmed:ownerNLMlld:pubmed
pubmed-article:15389235pubmed:authorsCompleteYlld:pubmed
pubmed-article:15389235pubmed:pagination475-80lld:pubmed
pubmed-article:15389235pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:meshHeadingpubmed-meshheading:15389235...lld:pubmed
pubmed-article:15389235pubmed:year2004lld:pubmed
pubmed-article:15389235pubmed:articleTitleExtended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).lld:pubmed
pubmed-article:15389235pubmed:affiliationHeart Center, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark. kjol-h@dadlnet.dklld:pubmed
pubmed-article:15389235pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15389235pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15389235pubmed:publicationTypeRandomized Controlled Triallld:pubmed